199 related articles for article (PubMed ID: 19902527)
21. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.
Unezaki S; Maruyama K; Takahashi N; Koyama M; Yuda T; Suginaka A; Iwatsuru M
Pharm Res; 1994 Aug; 11(8):1180-5. PubMed ID: 7971721
[TBL] [Abstract][Full Text] [Related]
22. Effects of poly(ethylene glycol) (PEG) chain length of PEG-lipid on the permeability of liposomal bilayer membranes.
Hashizaki K; Taguchi H; Itoh C; Sakai H; Abe M; Saito Y; Ogawa N
Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):815-20. PubMed ID: 12843588
[TBL] [Abstract][Full Text] [Related]
23. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
[TBL] [Abstract][Full Text] [Related]
24. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.
Kim HR; You DG; Park SJ; Choi KS; Um W; Kim JH; Park JH; Kim YS
Mol Pharm; 2016 May; 13(5):1528-39. PubMed ID: 26998616
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
Parr MJ; Masin D; Cullis PR; Bally MB
J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
[TBL] [Abstract][Full Text] [Related]
26. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
27. Disc formation in cholesterol-free liposomes during phase transition.
Ickenstein LM; Arfvidsson MC; Needham D; Mayer LD; Edwards K
Biochim Biophys Acta; 2003 Aug; 1614(2):135-8. PubMed ID: 12896806
[TBL] [Abstract][Full Text] [Related]
28. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
29. Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals.
Wu Y; Yang Y; Zhang FC; Wu C; Lü WL; Mei XG
J Liposome Res; 2011 Sep; 21(3):221-8. PubMed ID: 20929434
[TBL] [Abstract][Full Text] [Related]
30. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
Chiu GN; Abraham SA; Ickenstein LM; Ng R; Karlsson G; Edwards K; Wasan EK; Bally MB
J Control Release; 2005 May; 104(2):271-88. PubMed ID: 15907579
[TBL] [Abstract][Full Text] [Related]
31. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition.
Mills JK; Needham D
Biochim Biophys Acta; 2005 Oct; 1716(2):77-96. PubMed ID: 16216216
[TBL] [Abstract][Full Text] [Related]
32. The effect of thermosensitive liposomal formulations on loading and release of high molecular weight biomolecules.
Huang X; Li M; Bruni R; Messa P; Cellesi F
Int J Pharm; 2017 May; 524(1-2):279-289. PubMed ID: 28377318
[TBL] [Abstract][Full Text] [Related]
33. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
34. Current update of a thermosensitive liposomes composed of DPPC and Brij78.
Ho L; Bokharaei M; Li SD
J Drug Target; 2018; 26(5-6):407-419. PubMed ID: 29325469
[TBL] [Abstract][Full Text] [Related]
35. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.
Pasut G; Paolino D; Celia C; Mero A; Joseph AS; Wolfram J; Cosco D; Schiavon O; Shen H; Fresta M
J Control Release; 2015 Feb; 199():106-13. PubMed ID: 25499917
[TBL] [Abstract][Full Text] [Related]
36. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes.
Hossann M; Wiggenhorn M; Schwerdt A; Wachholz K; Teichert N; Eibl H; Issels RD; Lindner LH
Biochim Biophys Acta; 2007 Oct; 1768(10):2491-9. PubMed ID: 17618599
[TBL] [Abstract][Full Text] [Related]
37. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
Webb MS; Saxon D; Wong FM; Lim HJ; Wang Z; Bally MB; Choi LS; Cullis PR; Mayer LD
Biochim Biophys Acta; 1998 Jul; 1372(2):272-82. PubMed ID: 9675310
[TBL] [Abstract][Full Text] [Related]
38. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations.
Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC
Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia.
Al-Jamal WT; Al-Ahmady ZS; Kostarelos K
Biomaterials; 2012 Jun; 33(18):4608-17. PubMed ID: 22459195
[TBL] [Abstract][Full Text] [Related]
40. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
